<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9E6E29A1-FFE3-487C-84F6-02CD1B6E313A"><gtr:id>9E6E29A1-FFE3-487C-84F6-02CD1B6E313A</gtr:id><gtr:name>National Institute for Biological Standards and Control (NIBSC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/869F0B29-11C9-4722-9E9E-205F6BC4F56D"><gtr:id>869F0B29-11C9-4722-9E9E-205F6BC4F56D</gtr:id><gtr:name>Tecan UK Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75"><gtr:id>AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75</gtr:id><gtr:name>Centre for Life</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/252189B3-135F-4D99-BFB7-0799A34A409C"><gtr:id>252189B3-135F-4D99-BFB7-0799A34A409C</gtr:id><gtr:name>Loughborough University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AA6E6E03-A703-45C0-8978-64589E5CECD4"><gtr:id>AA6E6E03-A703-45C0-8978-64589E5CECD4</gtr:id><gtr:name>University of A Coruna</gtr:name><gtr:address><gtr:line1>Campus da Zapateira</gtr:line1><gtr:line2>9 calle maestranza</gtr:line2><gtr:postCode>15001</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5C3D1AA-F273-458D-B776-CE02F592BECA"><gtr:id>D5C3D1AA-F273-458D-B776-CE02F592BECA</gtr:id><gtr:name>Nottingham Uni Hospitals NHS Trust</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>City Hospital campus</gtr:line1><gtr:line2>Hucknall Road</gtr:line2><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG5 1PB</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5C3D1AA-F273-458D-B776-CE02F592BECA"><gtr:id>D5C3D1AA-F273-458D-B776-CE02F592BECA</gtr:id><gtr:name>Nottingham Uni Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>City Hospital campus</gtr:line1><gtr:line2>Hucknall Road</gtr:line2><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG5 1PB</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9E6E29A1-FFE3-487C-84F6-02CD1B6E313A"><gtr:id>9E6E29A1-FFE3-487C-84F6-02CD1B6E313A</gtr:id><gtr:name>National Institute for Biological Standards and Control (NIBSC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/869F0B29-11C9-4722-9E9E-205F6BC4F56D"><gtr:id>869F0B29-11C9-4722-9E9E-205F6BC4F56D</gtr:id><gtr:name>Tecan UK Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75"><gtr:id>AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75</gtr:id><gtr:name>Centre for Life</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/252189B3-135F-4D99-BFB7-0799A34A409C"><gtr:id>252189B3-135F-4D99-BFB7-0799A34A409C</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AA6E6E03-A703-45C0-8978-64589E5CECD4"><gtr:id>AA6E6E03-A703-45C0-8978-64589E5CECD4</gtr:id><gtr:name>University of A Coruna</gtr:name><gtr:address><gtr:line1>Campus da Zapateira</gtr:line1><gtr:line2>9 calle maestranza</gtr:line2><gtr:postCode>15001</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6D93C4B4-6A1A-4858-8A69-03438AAFF1FC"><gtr:id>6D93C4B4-6A1A-4858-8A69-03438AAFF1FC</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Denning</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G113%2F30"><gtr:id>1005355A-35F2-4AEB-9C41-1AB65155EF95</gtr:id><gtr:title>Gene targeting in human embryonic stem cells: A novel in vitro approach to modelling Duchenne Muscular Dystrophy (DMD)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G113/30</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>158872</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genome editing (Skarnes)</gtr:description><gtr:id>4A417867-AC50-4AE2-BDB7-EF00BA75ECE3</gtr:id><gtr:impact>Attracted several new grants of value &amp;pound;2m, introduced new skills to the team, leading to new national / international collaborations</gtr:impact><gtr:outcomeId>545a658b560902.30496893-1</gtr:outcomeId><gtr:partnerContribution>Carrying out the research and intellectual input</gtr:partnerContribution><gtr:piContribution>Skills exchange and training for staff in Nottingham</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centre for Life</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DMD (Lochmuller)</gtr:description><gtr:id>764072E3-68CA-40C2-BE0B-80F6B84C0D77</gtr:id><gtr:impact>grants &amp;amp; publications</gtr:impact><gtr:outcomeId>YWqGKSFscrR-1</gtr:outcomeId><gtr:partnerContribution>publications &amp;amp; grant</gtr:partnerContribution><gtr:piContribution>led research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tecan UK Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Automation (Development of robot)</gtr:description><gtr:id>BFF0FB40-DAB1-4A71-A8BB-A2FAA5FCAE59</gtr:id><gtr:impact>Publications, grants</gtr:impact><gtr:outcomeId>566834cb8bb7f5.94671443-1</gtr:outcomeId><gtr:partnerContribution>Role in automation</gtr:partnerContribution><gtr:piContribution>Bespoke robotic platform for automated culture and differentiation of human stem cells</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pluriomics BV</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Sharing hiPSC lines (Pluriomics)</gtr:description><gtr:id>944E3496-762D-4199-8B64-B6230BCC34DB</gtr:id><gtr:impact>Braam SR, Tertoolen L, Casini S, Matsa E, Lu HR, Teisman A, Passier R, Denning C, Gallacher DJ, Towart R, Mummery CL. (2012) Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Research. 10(1):48-56. PMID: 23089628</gtr:impact><gtr:outcomeId>aeuEVscVWJK-1</gtr:outcomeId><gtr:partnerContribution>Used our resources and input to carry out project</gtr:partnerContribution><gtr:piContribution>Provision of hiPSC lines, intellectual input to project</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DM1 grant &amp;amp; activity (Lochmuller)</gtr:description><gtr:id>902CAFA0-9BAC-4498-8138-A0E168159583</gtr:id><gtr:impact>Joint grant, hence economic</gtr:impact><gtr:outcomeId>56c49508c27f77.14757511-1</gtr:outcomeId><gtr:partnerContribution>Academic collaboration; joint posts; sharing of reagents and data</gtr:partnerContribution><gtr:piContribution>Joint BHF grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Safety Assessment GSK</gtr:department><gtr:description>Industrial collaboration (GSK via CRACK-IT)</gtr:description><gtr:id>DDA9ED9F-7ADA-44B4-B57F-0055E8A1018F</gtr:id><gtr:impact>Financial, international collaboration, skills sharing, joint PhD students, researcher exchange</gtr:impact><gtr:outcomeId>545a64c88cd145.80266414-1</gtr:outcomeId><gtr:partnerContribution>Implicit in the sponsorship and construction of the challenge</gtr:partnerContribution><gtr:piContribution>Facilitated award of NC3Rs CRACK-IT grant</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of A Coru?a</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Spannish patients (Roberto Barriales-Villa)</gtr:description><gtr:id>5387A503-D5F6-48CB-A796-99EA3631241D</gtr:id><gtr:impact>provision of patient samples to underpin research</gtr:impact><gtr:outcomeId>56c49dc0c46f16.44164842-1</gtr:outcomeId><gtr:partnerContribution>provision of patient samples to underpin research</gtr:partnerContribution><gtr:piContribution>provision of patient samples to underpin research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Safety Assessment GSK</gtr:department><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>B1244D78-09A1-4D0D-BAC4-BD500E787D27</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:outcomeId>56c499183fc200.96964726-5</gtr:outcomeId><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Loughborough University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Engineering</gtr:department><gtr:description>BRIC - Loughborough</gtr:description><gtr:id>1BAE1374-9BBB-47B0-BDDC-CD97D03AAE69</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>VBVKBYEZsbW-1</gtr:outcomeId><gtr:piContribution>Research collaboration to secure funds</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maturation grant (Tinker, Smith, Fischer)</gtr:description><gtr:id>DA197966-CA9B-43DC-B73E-1BEC9B7B6A9C</gtr:id><gtr:impact>joint grant and development of equipment, new molecules, cell resources</gtr:impact><gtr:outcomeId>56c49bdf5c7444.56681291-2</gtr:outcomeId><gtr:partnerContribution>joint grant and development of equipment, new molecules, cell resources</gtr:partnerContribution><gtr:piContribution>joint grant and development of equipment, new molecules, cell resources</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Syngenta</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>syngenta</gtr:description><gtr:id>23793FDC-678D-4D3D-B6AF-31E27ED13E53</gtr:id><gtr:impact>advances in stem cell automation</gtr:impact><gtr:outcomeId>mXi9UB65kMq-1</gtr:outcomeId><gtr:partnerContribution>intellectual and financial input</gtr:partnerContribution><gtr:piContribution>stem cell automation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Biological Standards and Control (NIBSC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>8D8CBB8D-DA05-4C42-B665-05BA3134E95B</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:outcomeId>56c49b12309ed0.62774774-2</gtr:outcomeId><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MIT (Asha Patel, E-term)</gtr:description><gtr:id>655A862F-977A-465C-91C7-FA0AAF0B3914</gtr:id><gtr:impact>E-Term Fellowship and sabbatical</gtr:impact><gtr:outcomeId>56c49c71db6104.99462381-1</gtr:outcomeId><gtr:partnerContribution>E-Term Fellowship and sabbatical</gtr:partnerContribution><gtr:piContribution>E-Term Fellowship and sabbatical</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hamburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>09BA8E77-97E0-47A2-BB2C-6D673CF14263</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:outcomeId>56c499183fc200.96964726-3</gtr:outcomeId><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Sciences Nottingham</gtr:department><gtr:description>LQT (Staniforth)</gtr:description><gtr:id>37F8B70C-F927-4AC4-802D-D059B93CCDC3</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:outcomeId>o2Nkx5EU2hm-1</gtr:outcomeId><gtr:partnerContribution>publications</gtr:partnerContribution><gtr:piContribution>led collab</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maturation grant (Tinker, Smith, Fischer)</gtr:description><gtr:id>3AD79707-CC72-489D-9FC7-FEF7B1724997</gtr:id><gtr:impact>joint grant and development of equipment, new molecules, cell resources</gtr:impact><gtr:outcomeId>56c49bdf5c7444.56681291-1</gtr:outcomeId><gtr:partnerContribution>joint grant and development of equipment, new molecules, cell resources</gtr:partnerContribution><gtr:piContribution>joint grant and development of equipment, new molecules, cell resources</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Electron</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>BDE9E000-2842-447C-8B8E-A4FE4C1EC9E0</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:outcomeId>56c49b12309ed0.62774774-3</gtr:outcomeId><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>DD27258C-F88D-4C33-8DBB-0102D50AA7C0</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:outcomeId>56c499183fc200.96964726-2</gtr:outcomeId><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Imperial (Sian Harding)</gtr:description><gtr:id>5E6C897E-7B8C-412E-AFA7-6C9863835143</gtr:id><gtr:impact>multiple activities on grants, papers, sharing skills, reagents etc</gtr:impact><gtr:outcomeId>56c49a1142e2e4.02796051-1</gtr:outcomeId><gtr:partnerContribution>multiple activities on grants, papers, sharing skills, reagents etc</gtr:partnerContribution><gtr:piContribution>multiple activities on grants, papers, sharing skills, reagents etc</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>9C685782-EE64-4C58-AE0A-1F6DA9A74AD2</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:outcomeId>56c49b12309ed0.62774774-1</gtr:outcomeId><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>3A91E8F3-F3A1-419B-AFF3-2B3B3B5E2824</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:outcomeId>56c49b12309ed0.62774774-4</gtr:outcomeId><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pluriomics BV</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>3211EAB0-23AC-4426-8FAC-6636EF0185D4</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:outcomeId>56c499183fc200.96964726-1</gtr:outcomeId><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technion - Israel Institute of Technology</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>BIRAX interactions (Mummery, Gepstein)</gtr:description><gtr:id>0DDFB3BD-9565-4AB0-89B3-4C7C763882FE</gtr:id><gtr:impact>Early stage at present</gtr:impact><gtr:outcomeId>56683ff4c13ad3.30900821-1</gtr:outcomeId><gtr:partnerContribution>Skills in progenitor cell biology and cell transplantation in vivo</gtr:partnerContribution><gtr:piContribution>New partnership between three labs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>virus (Dave Darling)</gtr:description><gtr:id>1324FE30-DDBB-4E22-BD6B-68DA75634C63</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>QhYKAPgQjJQ-1</gtr:outcomeId><gtr:partnerContribution>publications</gtr:partnerContribution><gtr:piContribution>led collab</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Electrophysiology mechanisms (Harmer / Tinker)</gtr:description><gtr:id>502E4D9A-A4E9-4708-94BC-0615C3A90680</gtr:id><gtr:impact>grants awarded. Papers in progress</gtr:impact><gtr:outcomeId>566835790bbfd5.22216485-1</gtr:outcomeId><gtr:partnerContribution>Skills in detailed electrophyioslogy</gtr:partnerContribution><gtr:piContribution>mechanism of electrophysiology in hPSC-cardiomyocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>exon skipping (Leiden, Aartsma-Rus)</gtr:description><gtr:id>FE381FA4-BDBE-47DF-925F-409F835FF99B</gtr:id><gtr:impact>Publication of paper</gtr:impact><gtr:outcomeId>bVRNQ7bRpJ7-1</gtr:outcomeId><gtr:partnerContribution>reagents and expertise in exon skipping</gtr:partnerContribution><gtr:piContribution>brought skills to the team not available in Nottingham</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>DE7D509A-4944-4B32-AD82-19E297982AC3</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:outcomeId>56c499183fc200.96964726-4</gtr:outcomeId><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>surface work (Morgan Alexander, Nottingham)</gtr:description><gtr:id>98582688-C132-4467-925D-B25727A55E32</gtr:id><gtr:impact>grants and papers</gtr:impact><gtr:outcomeId>ZhDKKvYPNMS-1</gtr:outcomeId><gtr:partnerContribution>Multiple grant awards and papers</gtr:partnerContribution><gtr:piContribution>lead the stem cell work of this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>electrophysiology (CPVT, George / Williams)</gtr:description><gtr:id>A096CD04-DB0F-4EF0-8ABC-F1A86B428B67</gtr:id><gtr:impact>Grant secured. Working towards papers</gtr:impact><gtr:outcomeId>Y4oLF7euVg3-1</gtr:outcomeId><gtr:partnerContribution>Developed to &amp;pound;1.1m BHF grant</gtr:partnerContribution><gtr:piContribution>electrophysiology of cardiomyocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Channel 4</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F9DD5B13-36D7-461F-A6EE-E3EF82ED22D4</gtr:id><gtr:impact>Featured on channel 4 documentary

disseminated to wider public</gtr:impact><gtr:outcomeId>cWMPrhFyRmn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SkyNews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EBA194B9-2616-4116-BC90-8B60CB5BE9A5</gtr:id><gtr:impact>Watched by 13 million people

interest in research group</gtr:impact><gtr:outcomeId>56683adc98df03.69243916</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF - Welcome booklet imaging (Sorrel Bunting Oct 2016)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>411C8F7E-A6E5-47D6-8787-86B68A92D996</gtr:id><gtr:impact>Information booklet commissioned by BHF and Wellcome Trust to support research against cardiovascular disease</gtr:impact><gtr:outcomeId>58bd9230306f84.78805868</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC East Midlands Today - BHF education on heart disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>86C53DCC-268A-463B-AC27-6D5884B23C98</gtr:id><gtr:impact>Interview with BBC East Midlands Today to educate on importance for research for heart disease</gtr:impact><gtr:outcomeId>58bd93d2937070.43970298</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog in Huffington post</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>312AF8BB-2C6E-4B3F-BACE-C981B2CFB8B7</gtr:id><gtr:impact>Blog in Huffington Post which promoted new grant - global reach</gtr:impact><gtr:outcomeId>56a8d1b68d23d7.23368025</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.huffingtonpost.co.uk/simon-gillespie/valentines-day_b_6669914.html?utm_hp_ref=science</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heart Res UK case study for AMRC (Nov 2016)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E73C7AB5-C95B-4AB4-B73B-C068D954ADAE</gtr:id><gtr:impact>Case study / newsletter from Heart Research UK grant to educate on need for new medicines for heart disease</gtr:impact><gtr:outcomeId>58bd91b6051f85.94899729</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited conference presentation during 2016-2017 reporting period</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4D34D2F7-275B-4050-957C-ED3775819DEF</gtr:id><gtr:impact>Presented at &amp;gt;20 international conferences in Europe, Middle East, Asia and USA, each having 50 to 500 delegates from professional academic, public, media, patient and industry</gtr:impact><gtr:outcomeId>58bd9cc77b1162.31427559</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media (as a channel to the public)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>062D20CF-9855-4302-AD29-6F6859F33670</gtr:id><gtr:impact>- Provision of short articles to magazines such as BioWorld International, BBSRC business, Hospital Solutions - Interview with newspapers, such as Daily Mail, Telegraph etc organised through the Science Media Centre in London - Interviewed and filmed by BBC Scotland 6 O'clock news and BBC / ITV local news stations

Increased public perception and acceptance of the importance of stem cells. Increased application rates from PhD students to our unit</gtr:impact><gtr:outcomeId>C475BBBE1D7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF public information booklet on research</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2A153A5E-E60F-4D9A-8C0F-8865B208A87F</gtr:id><gtr:impact>British people with interest in heart disease engaged

to early to be determined but acts as part of continual BHF effort to raise funds</gtr:impact><gtr:outcomeId>aJbMWUQQfkQ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF news advert / article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>924BDA41-9B38-4E9B-B807-99A8BDE78620</gtr:id><gtr:impact>Advertising in national newspaper

to early to tell but part of BHF effort to continually raise funds</gtr:impact><gtr:outcomeId>b8HKUGj2ygu</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>observer</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>31255642-ADA2-45C4-B134-C8A59C103EF2</gtr:id><gtr:impact>Interview with Observer on hiPSC-based cardiovascular work

national press and engagement with public</gtr:impact><gtr:outcomeId>oFRvRj7fxZS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nottingham press release (EPSRC ?6.5m project)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EA4869D5-93B2-4FF5-990C-6D248700E652</gtr:id><gtr:impact>Press release leading to new interactions</gtr:impact><gtr:outcomeId>56a8d3ecef8948.79524957</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/news/pressreleases/2015/august/3d-vision-for-the-next-generation-of-biomaterials.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC radio Nottingham (Heart-light)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>18C4F313-2522-4429-8787-A82DB4B49268</gtr:id><gtr:impact>Public engaged on new research grant</gtr:impact><gtr:outcomeId>56a8d207155889.31033429</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF Visit Outreach for Sorrel Bunting (Nov 2016)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>704C0B9A-7B7E-4687-A114-336205B456F8</gtr:id><gtr:impact>Group of 20 workers from BHF, including shop-runners, fund raisers, office workers</gtr:impact><gtr:outcomeId>58bd90decca4e1.16643093</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public engagement day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9075D180-BAAC-4B5F-A03F-1CB3A5A177D5</gtr:id><gtr:impact>250 members of the public attended the British Society for Gene Therapy public day in Brighton

active engagement and enthusiasm from members of the public</gtr:impact><gtr:outcomeId>KAvMdFBjrt2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sara Pijuangalito (Times article on stem cell expansion, July 2016)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>22E7DC21-2A13-4CE4-847B-462852EBA42A</gtr:id><gtr:impact>New methods for stem cell manufacture picked up by The Times Newspaper</gtr:impact><gtr:outcomeId>58bd92fe3cef43.27333931</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.thetimes.co.uk/article/scientists-discover-way-to-mass-produce-stem-cells-cxr2mcqgc</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nottingham press release (new biomaterials)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>71739638-8A5B-47F8-B633-2672CB7895CA</gtr:id><gtr:impact>nottingham press release on new publication. Led to additional funding and interaction</gtr:impact><gtr:outcomeId>56a8d39b3cb780.37985628</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/news/pressreleases/2015/july/new-material-forges-the-way-for-stem-cell-factories.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BIRAX press release in May 2016 to promote heart therapies</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3E8A7528-8F9C-4048-9FDF-AE307432CD57</gtr:id><gtr:impact>Promoting research into treatments for heart disease</gtr:impact><gtr:outcomeId>58bd945e06d3c6.52746516</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Observer &amp; Guardian on Sunday 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F698D6D1-A658-4C40-B15D-1BBADB74DFE5</gtr:id><gtr:impact>Description of research to National newspapers

follow up enquiries and public engagement</gtr:impact><gtr:outcomeId>545b876b09d0d6.40854822</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nottingham press release (heart light)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>86D25A38-94E9-41EF-98CE-558A76B20C7C</gtr:id><gtr:impact>Press release on new grant</gtr:impact><gtr:outcomeId>56a8d333520bc7.47945936</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/news/pressreleases/2015/february/light-sensitive-proteins-could-help-mend-our-broken-hearts.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D16E7F62-FD67-44BD-9D55-B53E911F3739</gtr:id><gtr:impact>more interest in lab / education

interest in lab / education</gtr:impact><gtr:outcomeId>56683b57b9a2e4.57328060</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>public engagement day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>010861EE-E8BE-42B9-9100-3B25918CDFAC</gtr:id><gtr:impact>The engagement day was attended by approx 250 members of the public

good attendance and feedback will mean the event will be run again in 2013.</gtr:impact><gtr:outcomeId>KCYgMU7rPWa</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asha E-term fellowship</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>633D76C9-7890-445F-B05A-C21A4704DEB4</gtr:id><gtr:outcomeId>545a66b7837f10.39264252</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 2</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>36CD1031-EFB4-4C8F-AAF6-AED9A2F54F4C</gtr:id><gtr:outcomeId>545a681e0ba047.28266204</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>475000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Programme Grant (2 pilot with Sian Harding)</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/11/19/29264</gtr:fundingRef><gtr:id>4E44A7B4-61B1-4E58-B4F7-F138C1DCA89F</gtr:id><gtr:outcomeId>abKcb9zHRW9</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC equip - seahorse</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>04146E37-5C7A-4EE3-9697-2066117C9087</gtr:id><gtr:outcomeId>545a67ec910b43.40227873</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC 'Future-Proof' Synthetic Surfaces</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H045384/1</gtr:fundingRef><gtr:id>337FB77E-C9F2-48D2-8DAB-F7C53D088C14</gtr:id><gtr:outcomeId>pvZ7AvEuhNT0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SC4SM cardiomyocyte call</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Stem Cells for Safer Medicines (SC4SM)</gtr:fundingOrg><gtr:id>A9462173-7D25-46F4-9439-D4F4A83C79F2</gtr:id><gtr:outcomeId>811ED065AB40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5259190</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EP/H028277/1 EPSRC Centre for Innovative Manufacturing in Regenerative Medicine</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H028277/1</gtr:fundingRef><gtr:id>0FD09A3A-8502-41B1-BF12-85E656B61B18</gtr:id><gtr:outcomeId>MvtRXSXTorT0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF programme 2014-17</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>427A7F4F-6213-4CAA-AD70-9FD45973081B</gtr:id><gtr:outcomeId>545a67b5280e91.42192171</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>602000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Nottingham Strategic Development Fund &amp;quot;Nottingham Regenerative Medicine Centre&amp;quot; 1.1.15-31.12.18. &amp;pound;602,140 (PI)</gtr:description><gtr:end>2020-10-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:fundingRef>n/a</gtr:fundingRef><gtr:id>3F1216D1-22AB-4BDF-ADE2-6D54212AB21D</gtr:id><gtr:outcomeId>5668367913d0a9.91277416</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BIRAX grant 04BX14CDLG. Gene targeted optogenetics in hPSC-cardiovascular cells for transplantation into animal models of heart dysfunction. 1.9.15-31.8.18. &amp;pound;400K</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>04BX14CDLG</gtr:fundingRef><gtr:id>69B06FE7-A987-47B8-B5D8-B69D3464F675</gtr:id><gtr:outcomeId>566837217b3b72.39646891</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>515000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs main panel (Viola)</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>NC/K000225/1</gtr:fundingRef><gtr:id>161A9B01-1C4F-4078-B856-FA04B15EBEB0</gtr:id><gtr:outcomeId>VawBCaNLuuQ</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>714000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC capital equipment</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012618/1</gtr:fundingRef><gtr:id>7C73F3CB-C6FA-45A9-8DFD-0031D1BF18DC</gtr:id><gtr:outcomeId>545a67134da282.80690766</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BHF Special Project no. SP/15/9/31605. &amp;quot;Coupling gene targeted reporters with fully automated compound library screening to mature hPSC-cardiomyocytes&amp;quot;.</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>SP/15/9/31605</gtr:fundingRef><gtr:id>CCBF1EF9-05B8-4A4B-9FA4-C6782C10971B</gtr:id><gtr:outcomeId>56683820d4d335.79135953</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? EPSRC Programme Grant EP/N006615/1: 'Next Generation Biomaterials Discovery'. PI: Morgan Alexander. Multiple Co-Is. 1.10.15-30.9.20. &amp;pound;6.6m</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/N006615/1</gtr:fundingRef><gtr:id>6C298EAB-899B-4889-B89F-CE1F8CC768CD</gtr:id><gtr:outcomeId>566837d8b83fc5.74010917</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Heart Res UK (Divya)</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:fundingRef>TRP01/12</gtr:fundingRef><gtr:id>65426D6E-C8FA-4CCB-8763-F118427BE8FC</gtr:id><gtr:outcomeId>eh4j6Cf2pqp</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? EPSRC Impact Accelerator Award. A Strategic Partnership with the Australian Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM) to Commercialise Stem Cell Culture Polymers</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>n/a</gtr:fundingRef><gtr:id>AF7ADEDC-36A2-461A-86D9-A9B993ADB6A7</gtr:id><gtr:outcomeId>566838570250c7.82075737</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Int studentship - spandan</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:id>392DA936-4A94-436D-B4A4-BB15D5ED3022</gtr:id><gtr:outcomeId>hMwiv8LHFXN0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre for Regen Med</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>P47352/</gtr:fundingRef><gtr:id>CD2A0983-057E-48F1-B122-EF1D6984BB64</gtr:id><gtr:outcomeId>545a67552211c3.59015186</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BHF Programme Grant RG/15/6/31436: Predicting anti-arrhythmic drug efficacy from the divergent molecular basis of RyR2 dysfunction in genetic arrhythmia syndromes</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/15/6/31436</gtr:fundingRef><gtr:id>1DF8DAD5-5411-434F-B6FC-F02CEDC68239</gtr:id><gtr:outcomeId>5668377c59c035.77232407</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>36000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMDA</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>East Midlands Development Agency (EMDA)</gtr:fundingOrg><gtr:id>3F30463B-C792-49A5-A6C1-D6FAA4347749</gtr:id><gtr:outcomeId>e7uHkP6MzSb0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>epsrc DTG (Asha)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>377B5372-CA4C-44C4-AACE-7C35080B20AB</gtr:id><gtr:outcomeId>FczMvMb4E7X0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF MyoD grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/14/59/31000</gtr:fundingRef><gtr:id>A4FF44F2-8E5C-4706-9863-631915C777E8</gtr:id><gtr:outcomeId>545a68487de779.98354875</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 1</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>BDFC7CC4-D736-4DD5-8045-60208C75E242</gtr:id><gtr:outcomeId>545a6783d82078.61058075</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU - dave</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>99F37A73-C5D3-46FB-9795-7B3CC53C366A</gtr:id><gtr:outcomeId>KwNdZpEHbtX0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? MRC grant MR/M017354/1: MICA: Development of Metrics and Quality Standards for Scale up of Human Pluripotent Stem Cells. 1.5.15-30.4.17 &amp;pound;1.</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M017354/1</gtr:fundingRef><gtr:id>04A73579-86A0-41A4-8CCC-099D58E099D6</gtr:id><gtr:outcomeId>566836dfcaa495.41859778</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC IPA</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>E453E07B-2A6F-4FC1-BC64-D106B8AF27FD</gtr:id><gtr:outcomeId>jdGsnSsbNju0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DMD grant 2009</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8A0EA602-C302-4824-9212-4286A2BEF82D</gtr:id><gtr:outcomeId>9120C9B37BD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>189000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF LQTS grant (Elena)</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>281B660C-2979-4D3A-90CC-819AE75D9995</gtr:id><gtr:outcomeId>inEJQeFeC4m0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Patent filed to cover new synthetic substrate to culture human embryonic stem cells</gtr:description><gtr:grantRef>G113/30</gtr:grantRef><gtr:id>E8EEF4AB-8DB9-478B-BDDF-185DB1B92885</gtr:id><gtr:impact>Negotiations with major plasticware companies in progress through Nottingham's tech trasnfer office</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>3E7FC88F86D</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>New synthetic culture surfaces for human embryonic stem cells</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>This invention relates to transduction of cargo molecules into living cells, such as protein transduction, in particular a delivery molecule for transduction of a cargo into a cell comprising: a cargo-binding molecule and/or a cargo; a glycosaminoglycan (GAG) binding element, which is capable of binding to GAG on the surface of the cell; and a protein transduction domain. Methods of transduction, methods of producing or modifying cargo for transduction, delivery molecules for transduction and methods of treatment using transduction, or using transduced cells are also provided.</gtr:description><gtr:grantRef>G113/30</gtr:grantRef><gtr:id>B94466F2-A1E3-4430-8550-9F209AA467BD</gtr:id><gtr:impact>Scientific development with view to licensing.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56c49f1f2a5b61.91083859</gtr:outcomeId><gtr:patentId>WO2015092417</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>GET system with James &amp;amp; Kevin</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>optical spectra for cardiomyocytes using Raman microspectroscopy defined</gtr:description><gtr:grantRef>G113/30</gtr:grantRef><gtr:id>88BC2583-3D4C-41EF-827F-C4FB869EB623</gtr:id><gtr:impact>linking into partners within the Bioprocess Research Industry Club</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>Sd1vgG56gqo</gtr:outcomeId><gtr:patentId>GB1018628.6</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Raman</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EU Stem Cell Patents</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8E89B27F-47E8-418C-A33A-518CF3116A0F</gtr:id><gtr:outcomeId>59C539F64BD</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Masters course</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>650B1241-B8C2-443D-ABDA-5B86B1724FBF</gtr:id><gtr:impact>masters levels training in stem cell technologies</gtr:impact><gtr:outcomeId>mH1VLePfr25</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NC3Rs policy document on regenerative medicine (Kevin Shakesheff 2015)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B47FEA55-8DEC-4D82-A926-8BD955F81C49</gtr:id><gtr:outcomeId>56c49e41d25ed6.20884474</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7A43EBC5-1E4E-4729-AA70-5B20EBB06B68</gtr:id><gtr:outcomeId>heUqr1wcYpi</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>genome editing techniques and cell lines</gtr:description><gtr:id>CA68E4E5-1CFC-4706-8D3B-1C68952D9E36</gtr:id><gtr:impact>developing UK and EU portfolio of research tools and assisting collaborations / grants</gtr:impact><gtr:outcomeId>545a69cfa445e9.86861247</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>genome editing</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We derived 2 new human ES cell lines (NOTT1 and NOTT2) that were deposited to the UK Stem Cell Bank and are available for distribution</gtr:description><gtr:id>B9F985DD-BED0-4294-965B-BDD6D30346DC</gtr:id><gtr:impact>Availability of new human ES cell lines for academic use</gtr:impact><gtr:outcomeId>4C479244EDF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human ES cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>hiPSC lines carrying mutations in long QT syndrome genes</gtr:description><gtr:id>35A65B2F-C34F-45A0-8754-DAA97C17CBB8</gtr:id><gtr:impact>1. Braam SR, Tertoolen L, Casini S, Matsa E, Lu HR, Teisman A, Passier R, Denning C, Gallacher DJ, Towart R, Mummery CL. (2012) Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Research. 10(1):48-56. PMID: 23089628</gtr:impact><gtr:outcomeId>syTV8Z9N7hg</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>hiPSC lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://europepmc.org/abstract/MED/23089628</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F2AE8E5F-6B62-467C-BEAC-190675CE93E9</gtr:id><gtr:title>Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity</gtr:title><gtr:parentPublicationTitle>Drug Discovery Today: Therapeutic Strategies</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>589d8a690b5747.83103468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A05E77-3D35-4702-A22C-77D472CEC7F9</gtr:id><gtr:title>Bioluminescence imaging of human embryonic stem cells transplanted in vivo in murine and chick models.</gtr:title><gtr:parentPublicationTitle>Cloning and stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39e2fb8c5f522f60194815ba57656b6d"><gtr:id>39e2fb8c5f522f60194815ba57656b6d</gtr:id><gtr:otherNames>Priddle H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1536-2302</gtr:issn><gtr:outcomeId>69BA4A726C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A3136DB-271D-4BEC-BBDA-7E6C2E294DD6</gtr:id><gtr:title>Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>6201C7BAD27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0585F00-F472-40D8-8316-EF0D0993FD83</gtr:id><gtr:title>A multielectrode array (MEA) biochip with excimer laserproduced microwell features</gtr:title><gtr:parentPublicationTitle>Circuit World</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68809d33eb7e2bf2fd3588f99f6fdd33"><gtr:id>68809d33eb7e2bf2fd3588f99f6fdd33</gtr:id><gtr:otherNames>Flaherty O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>HkqqvgXJFZj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BADAD18D-D8C3-4A03-B333-A7AE902E1397</gtr:id><gtr:title>Scaling human pluripotent stem cell expansion and differentiation: are cell factories becoming a reality?</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ee80f93fb699e3ce06d44043a7ef99d"><gtr:id>3ee80f93fb699e3ce06d44043a7ef99d</gtr:id><gtr:otherNames>Smith JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>566831a2770099.16364282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB2BF42D-DBFA-473B-B522-690BD7AECD33</gtr:id><gtr:title>Maintenance of pluripotency in human embryonic stem cells cultured on a synthetic substrate in conditioned medium.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be02904063843eff826855654d7e9247"><gtr:id>be02904063843eff826855654d7e9247</gtr:id><gtr:otherNames>Mahlstedt MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>nMtk949YQyo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8324C849-4BAB-4428-90E4-694F021D1FFB</gtr:id><gtr:title>Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>456B5591F18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1021B6E-7C5D-47D4-BAC0-7BC6A88F9F6F</gtr:id><gtr:title>Derivation and characterisation of the human embryonic stem cell lines, NOTT1 and NOTT2.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39e2fb8c5f522f60194815ba57656b6d"><gtr:id>39e2fb8c5f522f60194815ba57656b6d</gtr:id><gtr:otherNames>Priddle H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>efsbwKUFgwH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF68921A-B6BB-4E6F-B978-2E4F0CF92442</gtr:id><gtr:title>Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>pm_13243_23_23089628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A70658BF-AAF0-44CC-B53A-B45BEAB5391D</gtr:id><gtr:title>Chemically diverse polymer microarrays and high throughput surface characterisation: a method for discovery of materials for stem cell culture?Electronic supplementary information (ESI) available. See DOI: 10.1039/c4bm00054dClick here for additional data file.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn><gtr:outcomeId>545a6299be25e0.66360021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E26872EF-09B0-476E-AD53-9756E52FFDC0</gtr:id><gtr:title>Current status of drug screening and disease modelling in human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_13243_23_22886688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F2E7FF9-6DDD-49D6-A568-6BEC2142DA0E</gtr:id><gtr:title>Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>QyYd3WAdR8P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E99816B-72F9-40C2-9865-22E1F695CA3C</gtr:id><gtr:title>Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation.</gtr:title><gtr:parentPublicationTitle>Advanced materials (Deerfield Beach, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0935-9648</gtr:issn><gtr:outcomeId>566831a2cd0689.40495220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5314A071-EF4D-4ABA-898D-8FC3EAF50546</gtr:id><gtr:title>Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56c49318aea877.58554434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CD70B7F-7684-4F8C-99CC-E8F8B7788F01</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_13243_23_22119741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0611A010-E20E-4EB5-85AE-617AE0E82C37</gtr:id><gtr:title>Rapid micropatterning of cell lines and human pluripotent stem cells on elastomeric membranes.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87660c95d65a3011d13d00df19cbec1f"><gtr:id>87660c95d65a3011d13d00df19cbec1f</gtr:id><gtr:otherNames>Paik I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>aBEw2wgMEoi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15133ED2-D888-43FE-9F76-92A2395B43E4</gtr:id><gtr:title>Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ba577c6d3ec3aa14281199806ff0d41"><gtr:id>6ba577c6d3ec3aa14281199806ff0d41</gtr:id><gtr:otherNames>Lin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>566831a30c46a0.92656705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49CE4147-F40D-411A-AAB0-7F4D82C5E06D</gtr:id><gtr:title>Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0bea90aaf075c744a2fc62a831a6fa5"><gtr:id>a0bea90aaf075c744a2fc62a831a6fa5</gtr:id><gtr:otherNames>Burridge PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>02D4C73BF8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>352FADA9-E733-4C68-876D-2850E8AB4655</gtr:id><gtr:title>In vitro uses of human pluripotent stem cell-derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular translational research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1937-5387</gtr:issn><gtr:outcomeId>pm_13243_23_22639342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB0C77BC-6A24-4A8D-A7E4-6E190E4EEE15</gtr:id><gtr:title>Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f098469dc1dbb18dc75ff4bb9372c1b"><gtr:id>7f098469dc1dbb18dc75ff4bb9372c1b</gtr:id><gtr:otherNames>Goldring C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>589d8a675a6da5.27031921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBB27689-9DEC-4B32-BAD0-0A3BCF5B04D0</gtr:id><gtr:title>Stem Cells - From Bench to Bedside</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:isbn>978-981-256-126-8</gtr:isbn><gtr:outcomeId>589d8a6bd318a9.41569810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25630467-35E5-4D0E-AE34-1109125DBE18</gtr:id><gtr:title>Human embryonic stem cells as a model for nutritional programming: an evaluation.</gtr:title><gtr:parentPublicationTitle>Reproductive toxicology (Elmsford, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/711d7c4345cd767e79003f4e4f4b46d2"><gtr:id>711d7c4345cd767e79003f4e4f4b46d2</gtr:id><gtr:otherNames>Allegrucci C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0890-6238</gtr:issn><gtr:outcomeId>E338FADC784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>571C0EA6-E73D-4E9E-90FB-4BD477BE66BB</gtr:id><gtr:title>Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/711d7c4345cd767e79003f4e4f4b46d2"><gtr:id>711d7c4345cd767e79003f4e4f4b46d2</gtr:id><gtr:otherNames>Allegrucci C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>52AD4EBFDFE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AB659E4-E9A5-49D9-AC5A-EC139669BDB0</gtr:id><gtr:title>Aberrant a-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f93743e559aafdfa1e2921addae87e"><gtr:id>44f93743e559aafdfa1e2921addae87e</gtr:id><gtr:otherNames>F?ldes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>566831a33a17b5.93053517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87E38CAF-B9E6-4EC1-9C82-33EF48767B85</gtr:id><gtr:title>Molecular and phenotypic analyses of human embryonic stem cell-derived cardiomyocytes: opportunities and challenges for clinical translation.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a00e5438cd5bc01dd9a7a079a217bb6"><gtr:id>6a00e5438cd5bc01dd9a7a079a217bb6</gtr:id><gtr:otherNames>Goh G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>FF777F1BCF4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31398401-7282-4F96-A690-BAD41C54F5EA</gtr:id><gtr:title>Transgenic enrichment of cardiomyocytes from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f1d9595d9be968fce9ee3d8dd1e7fc"><gtr:id>25f1d9595d9be968fce9ee3d8dd1e7fc</gtr:id><gtr:otherNames>Anderson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>C1C85234C1D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>130C2800-1854-47D8-ABAB-A15E3A7EF3A3</gtr:id><gtr:title>Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60b455442d087bb32e62d7332e3ffb23"><gtr:id>60b455442d087bb32e62d7332e3ffb23</gtr:id><gtr:otherNames>van de Stolpe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>8741404E889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>840CEC45-C19D-4FAC-856C-5F5BC5ACF55F</gtr:id><gtr:title>Noninvasive detection and imaging of molecular markers in live cardiomyocytes derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>pm_13243_23_21190678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBD2C9A8-F4D3-40DB-A676-7E61E5AB01E1</gtr:id><gtr:title>The patentability of human embryonic stem cells in Europe.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2507f68508b9290828d51404281e0e33"><gtr:id>2507f68508b9290828d51404281e0e33</gtr:id><gtr:otherNames>Porter G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>10EFD7FFDF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8825453-44A0-4B1D-8A97-9F07B90BC856</gtr:id><gtr:title>Stem-cell consequences of embryo epigenetic defects.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/711d7c4345cd767e79003f4e4f4b46d2"><gtr:id>711d7c4345cd767e79003f4e4f4b46d2</gtr:id><gtr:otherNames>Allegrucci C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>FD434DF3373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5228EBDF-58EF-489D-A1F4-DB92744E5D67</gtr:id><gtr:title>Non-invasive label-free monitoring the cardiac differentiation of human embryonic stem cells in-vitro by Raman spectroscopy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>589d8a679219c1.05030904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4871CF1C-EF21-406B-8613-0BF9F7C5031F</gtr:id><gtr:title>Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>Zt3jYrQLivW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1B19798-1F53-4183-A89B-7B833EF262FB</gtr:id><gtr:title>Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98f52a1e300c8e07792521e8a804088f"><gtr:id>98f52a1e300c8e07792521e8a804088f</gtr:id><gtr:otherNames>Kim KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>174FA08A3E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7011A3C1-C454-421E-9C1C-6A6EF612F402</gtr:id><gtr:title>Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line</gtr:title><gtr:parentPublicationTitle>Reproductive BioMedicine Online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60b455442d087bb32e62d7332e3ffb23"><gtr:id>60b455442d087bb32e62d7332e3ffb23</gtr:id><gtr:otherNames>van de Stolpe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:outcomeId>589d8a6c3bdf53.04754967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE1A09FA-6BFA-45C4-91F7-407DE47832A7</gtr:id><gtr:title>Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>545a629a1c27f9.53824035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40482873-3EE6-417E-B448-DC3F2F77238F</gtr:id><gtr:title>Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>566831a234bbb9.71328458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5919FF4-3BD6-4385-A430-602443B15AB7</gtr:id><gtr:title>Directed differentiation of human embryonic stem cells to interrogate the cardiac gene regulatory network.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>pm_13243_23_21694703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4B14F3A-DA5C-4D00-81C0-17F46407FE17</gtr:id><gtr:title>Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>p83MbRqgBzH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C1A760F-6FEA-415C-89B5-5942A6E6DC74</gtr:id><gtr:title>Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545a629996af88.73290622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F236A8C-7BBD-4527-BEF2-D1D65B363E25</gtr:id><gtr:title>High throughput screening for discovery of materials that control stem cell fate</gtr:title><gtr:parentPublicationTitle>Current Opinion in Solid State and Materials Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d87383292ff314baabba8e48b3e9fc3a"><gtr:id>d87383292ff314baabba8e48b3e9fc3a</gtr:id><gtr:otherNames>Patel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>589d8a6718b837.00948576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3638EC71-AE3A-4FA3-BE53-2DFACD8703F8</gtr:id><gtr:title>Stem Cell Engineering</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34192f29560b0b65713c54929c16a254"><gtr:id>34192f29560b0b65713c54929c16a254</gtr:id><gtr:otherNames>Kane N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-3-642-11864-7</gtr:isbn><gtr:outcomeId>589d8a68433915.22131110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAE27E71-88F5-4693-A877-F9A17444A82E</gtr:id><gtr:title>Materials for stem cell factories of the future.</gtr:title><gtr:parentPublicationTitle>Nature materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1476-1122</gtr:issn><gtr:outcomeId>545a6299e721e5.09179201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E39FCBAE-1E50-49AD-ACA0-31959E6FA55B</gtr:id><gtr:title>Small molecule absorption by PDMS in the context of drug response bioassays.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fd58851f705a631b75ed1ceded0e823"><gtr:id>4fd58851f705a631b75ed1ceded0e823</gtr:id><gtr:otherNames>van Meer BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>589d8a66c8f384.10722477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>736BBD18-ABEC-441B-90C2-86EE3196F096</gtr:id><gtr:title>Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>pm_13243_23_21095172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E482DBF-8223-4498-A87B-E63F188781E3</gtr:id><gtr:title>A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f5a65ec20558965fa2d27363b8d946"><gtr:id>15f5a65ec20558965fa2d27363b8d946</gtr:id><gtr:otherNames>Patel AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>566831a2a20339.76663919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E62FEDE-1237-4B41-9D14-4C372F3AFE49</gtr:id><gtr:title>Automated, scalable culture of human embryonic stem cells in feeder-free conditions.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5cf6183ac946ce2727a4beac8290f2e"><gtr:id>a5cf6183ac946ce2727a4beac8290f2e</gtr:id><gtr:otherNames>Thomas RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>589d8a68ab7673.64812108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7D3CC3B-278A-435C-99E6-980149303C7B</gtr:id><gtr:title>Improved genetic manipulation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>B1DBD805755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4E8361C-B1DE-403B-8810-0184DAF95388</gtr:id><gtr:title>Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>589d8a66ee7154.90895501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE5EFD8-44B4-47F0-8EF5-8EA812B8006F</gtr:id><gtr:title>Toward label-free Raman-activated cell sorting of cardiomyocytes derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical optics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1083-3668</gtr:issn><gtr:outcomeId>pm_13243_23_21529069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>078F3900-F139-4CDF-B099-071C33D4604E</gtr:id><gtr:title>Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line</gtr:title><gtr:parentPublicationTitle>REPRODUCTIVE BIOMEDICINE ONLINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4a8ddd15a4c7ce99c7f79d3d1fd7031"><gtr:id>e4a8ddd15a4c7ce99c7f79d3d1fd7031</gtr:id><gtr:otherNames>de Stolpel AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>5a3513e4dba2f4.48837034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E83C992B-F2AD-48B2-B435-990F806E9454</gtr:id><gtr:title>Cardiomyocytes from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b5628b41fe8d44a70999ab3ab81fe28"><gtr:id>2b5628b41fe8d44a70999ab3ab81fe28</gtr:id><gtr:otherNames>Passier R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>59BD444CBDD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D96C0E8F-C3DC-40E9-A5BB-4FF01EBA534C</gtr:id><gtr:title>Oct4 during the pluripotency differentiation transition: who is regulating the regulator</gtr:title><gtr:parentPublicationTitle>Regenerative Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172649dab7a38879608fe1416a9530ec"><gtr:id>172649dab7a38879608fe1416a9530ec</gtr:id><gtr:otherNames>Young L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>589d8a6a9b6af9.54836115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D71C09BD-AD1E-4757-AF2A-C9F8456EBDA2</gtr:id><gtr:title>Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>589d8a67771875.75144267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A34693FC-68EE-4105-863B-BEF279E2D1E7</gtr:id><gtr:title>5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/554888849f9058347fc5093fe6a0ca4f"><gtr:id>554888849f9058347fc5093fe6a0ca4f</gtr:id><gtr:otherNames>Almeida RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>pm_13243_23_22419071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DAD7526-D42E-41A0-B6C3-06314B5C34AC</gtr:id><gtr:title>Human embryonic stem cell methyl cycle enzyme expression: modelling epigenetic programming in assisted reproduction?</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5d0f5e5cfb5dcff0ccba972a613b6f4"><gtr:id>b5d0f5e5cfb5dcff0ccba972a613b6f4</gtr:id><gtr:otherNames>Steele W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>15002D8034A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>893C60BF-5E16-4526-8B80-4979A2BBF5D1</gtr:id><gtr:title>Genetic manipulation of human embryonic stem cells in serum and feeder-free media.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>XwQx71juxZE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F02AF96D-3DC2-4944-8B14-4283DE9E3569</gtr:id><gtr:title>Identification of polymer surface adsorbed proteins implicated in pluripotent human embryonic stem cell expansion.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12624f7c7748d454dbff9720d6c307a4"><gtr:id>12624f7c7748d454dbff9720d6c307a4</gtr:id><gtr:otherNames>Hammad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn><gtr:outcomeId>585d31a4a9e524.86714431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FAFB3DE-B3DE-4BD9-933C-3338CB76E6B3</gtr:id><gtr:title>Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?</gtr:title><gtr:parentPublicationTitle>Journal of neuromuscular diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98adbe4c2a1dde13837d93783963d6c0"><gtr:id>98adbe4c2a1dde13837d93783963d6c0</gtr:id><gtr:otherNames>Kalra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd8942585926.33175763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F086CC-C03C-4AEA-9EBD-E9B651524BEA</gtr:id><gtr:title>Exon skipping and gene transfer restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutations.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>545a629a40e395.84709913</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G113/30</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>